½ÃÀ庸°í¼­
»óǰÄÚµå
1624402

¼¼°èÀÇ ¼¼Æ÷ °Ý¸® ¹× ¼¼Æ÷ ºÐ¸® ½ÃÀå : Á¦Ç° À¯Çüº°, ±â¼úº°, ÃÖÁ¾»ç¿ëÀÚº°, ¿ëµµº°, Áö¿ªº°, ¹üÀ§ ¹× ¿¹Ãø

Global Cell Isolation Cell Separation Market By Cell Type, By Product, By Technique, By End User, By Application, By Geographic Scope and Forecast

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Verified Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 202 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼Æ÷ °Ý¸® ¹× ¼¼Æ÷ ºÐ¸® ¼¼°è ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø

¼¼Æ÷ °Ý¸® ¹× ¼¼Æ÷ ºÐ¸® ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 126¾ï 7,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç 2031³â¿¡´Â 395¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç 2024³âºÎÅÍ 2031³â±îÁö ¿¬Æò±Õ 16.87%ÀÇ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¼¼Æ÷ °Ý¸® ¹× ¼¼Æ÷ ºÐ¸®´Â ¿¬±¸, Áø´Ü ¹× Ä¡·á ¸ñÀûÀ¸·Î ÀÌÁ¾ È¥ÇÕ¹°¿¡¼­ ƯÁ¤ ¼¼Æ÷ À¯ÇüÀ» ºÐ¸®ÇÏ´Â µ¥ »ç¿ëµÇ´Â ±â¼úÀ» ¸»ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¹æ¹ýÀº ¸é¿ªÇÐ, ¾Ï ¿¬±¸, Àç»ýÀÇÇÐ µîÀÇ ºÐ¾ß¿¡¼­ ¸Å¿ì Áß¿äÇϸç, °úÇÐÀÚµéÀº ƯÁ¤ ¼¼Æ÷ÀÇ ±â´É°ú °Åµ¿À» ºÐ¸®ÇÏ¿© ¿¬±¸ÇÒ ¼ö ÀÖ½À´Ï´Ù. °³¹ß¿¡´Â ¹é½Å °³¹ßÀ» À§ÇÑ ¸é¿ª¼¼Æ÷ ºÐ¸®, Àç»ý Ä¡·á¸¦ À§ÇÑ Áٱ⼼Æ÷ Á¤Á¦, ¾Ï ¿¬±¸¸¦ À§ÇÑ Á¾¾ç¼¼Æ÷ ºÐ¸® µîÀÌ Æ÷ÇԵ˴ϴÙ.

¹Ì¼¼À¯Ã¼°øÇÐ ¹× ÀÚ±â Ȱ¼ºÈ­ ¼¼Æ÷ ºÐ·ù¿Í °°Àº ±â¼úÀÇ ¹ßÀüÀ¸·Î È¿À²¼º, Á¤È®¼º, È®À强ÀÌ Çâ»óµÇ¾î ¸ÂÃãÇü ÀÇ·á ¹× ¼¼Æ÷ Ä¡·á¿¡ ´ëÇÑ ÀÀ¿ëÀÌ È®´ëµÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¼¼Æ÷ °Ý¸® ¹× ¼¼Æ÷ ºÐ¸®ÀÇ ¹Ì·¡´Â ¸Å¿ì À¯¸ÁÇÕ´Ï´Ù.

¼¼°è ¼¼Æ÷ °Ý¸® ¹× ¼¼Æ÷ ºÐ¸® ½ÃÀå ¿ªÇÐ

ÁÖ¿ä ½ÃÀå ÃËÁø¿äÀÎ

¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡:

¾Ï°ú ÀÚ°¡¸é¿ªÁúȯÀ» Æ÷ÇÔÇÑ ¸¸¼ºÁúȯÀÇ ¹ßº´·ü Áõ°¡°¡ ¼¼Æ÷ºÐ¸® ±â¼úÀÇ ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é, ¾Ï ȯÀÚ´Â 2040³â±îÁö 2,950¸¸ ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, È¿°úÀûÀÎ Ä¡·á¸¦ À§ÇØ °íµµÀÇ ¿¬±¸ ¹æ¹ýÀÌ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù.

Àç»ýÀÇ·áÀÇ ¼ºÀå:

Àç»ýÀÇ·áÀÇ ¼ºÀå

Fortune Business InsightsÀÇ º¸°í¼­¿¡ µû¸£¸é, ¼¼°è Àç»ýÀÇ·á ½ÃÀåÀº 2026³â±îÁö 900¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, Ä¡·á¿ë Áٱ⼼Æ÷ ¹× Àü±¸¼¼Æ÷ ºÐ¸®¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇÒ °ÍÀ¸·Î Àü¸ÁÇϰí ÀÖ½À´Ï´Ù. Çϰí ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.

±â¼úÀÇ Áøº¸:

¹Ì¼¼À¯Ã¼°øÇÐ ¹× ÀÚµ¿ ¼¼Æ÷ ¼±º°°ú °°Àº ¼¼Æ÷ ºÐ¸®¹ýÀÇ ±â¼ú Çõ½ÅÀº ¼¼Æ÷ ºÐ¸® °øÁ¤ÀÇ È¿À²¼º°ú Á¤È®¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù.

¿¬±¸ °³¹ß ÅõÀÚ Áõ°¡:

»ý¹° ÀÇÇÐ ¿¬±¸¿¡ ´ëÇÑ ÀÚ±Ý Áö¿øÀÇ Áõ°¡´Â ¼¼Æ÷ °Ý¸® ¹× ¼¼Æ÷ ºÐ¸® ±â¼úÀÇ ¹ßÀü¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ ±¹¸³º¸°Ç¿ø(NIH)Àº 2022³â »ý¹°ÀÇÇÐ ¿¬±¸ ¿¹»êÀ» 470¾ï ´Þ·¯·Î º¸°íÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ´Ù¾çÇÑ ¿ëµµÀÇ »õ·Î¿î ¼¼Æ÷ ºÐ¸® ±â¼ú °³¹ßÀ» µÞ¹ÞħÇÏ´Â Áß¿äÇÑ ÅõÀÚ¶ó°í °­Á¶Çϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä °úÁ¦

³ôÀº ±â¼ú ºñ¿ë:

¼¼Æ÷ ºÐ¸® ¹× ºÐ¸®¿¡ ÇÊ¿äÇÑ °í°¡ÀÇ Àåºñ¿Í ½Ã¾àÀº °í°¡À̱⠶§¹®¿¡ ¼Ò±Ô¸ð ½ÇÇè½ÇÀ̳ª ½Ã¼³¿¡¼­´Â ÀÌ¿ëÀÌ Á¦ÇÑÀûÀÔ´Ï´Ù.

±â¼úÀû º¹À⼺:

¼¼Æ÷ºÐ¸® ±â¼úÀÇ ´ëºÎºÐÀº Àü¹®ÀûÀÎ ÈÆ·Ã°ú Àü¹®Áö½ÄÀÌ ÇÊ¿äÇϱ⠶§¹®¿¡ ½Ã¼³ÀÌ Àß °®Ãß¾îÁöÁö ¾ÊÀº ½Ã¼³¿¡¼­´Â º¸±Þ¿¡ Àå¾Ö°¡ µÉ ¼ö ÀÖ½À´Ï´Ù.

½Ã·áÀÇ ¿À¿°µµ:

¿À¿°Àº ¿¬±¸ ¼º°ú¿Í Ä¡·á Àû¿ë¿¡ Å« ¿µÇâÀ» ¹ÌÄ¥ ¼ö Àֱ⠶§¹®¿¡ ºÐ¸®µÈ ¼¼Æ÷ÀÇ ¼øµµ¿Í ¹«°á¼ºÀ» È®º¸ÇÏ´Â °ÍÀÌ ¾î·Æ½À´Ï´Ù.

±ÔÁ¦»óÀÇ Àå¾Ö¹°:

¼¼Æ÷ ±â¹Ý Á¦Ç°¿¡ ´ëÇÑ ±ÔÁ¦ ÇöȲ ÆÄ¾ÇÀº º¹ÀâÇÏ°í ½Ã°£ÀÌ ¿À·¡ °É¸®¸ç, ½Å±â¼úÀÇ ½ÃÀå ÁøÀÔÀ» Áö¿¬½Ãų ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä µ¿Çâ

ÀÚµ¿È­ ÅëÇÕ

¼¼Æ÷ °Ý¸® ¹× ¼¼Æ÷ ºÐ¸® °úÁ¤ÀÇ ÀÚµ¿È­°¡ ÁøÇàµÇ¸é¼­ È¿À²¼º°ú ÀçÇö¼ºÀÌ Çâ»óµÇ¾î ¿¬±¸ÀÚµéÀÌ ÀÌ·¯ÇÑ ±â¼úÀ» º¸´Ù ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

°³º° ¸ÂÃãÀÇ·áÀÇ ¼ºÀå

¸ÂÃãÇü ÀÇ·áÀÇ È帧Àº ƯÈ÷ ȯÀÚ °³°³ÀÎÀÇ ÇÁ·ÎÆÄÀÏ¿¡ µû¶ó Ä¡·á¹ýÀ» Á¶Á¤Çϱâ À§ÇÑ Á¤¹ÐÇÑ ¼¼Æ÷ ºÐ¸® ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

Áٱ⼼Æ÷ ¿¬±¸¿¡ ´ëÇÑ °ü½É

Áٱ⼼Æ÷ ¿¬±¸¿Í Àç»ýÀÇ·á¿¡ÀÇ Àû¿ëÀÌ °­Á¶µÇ¸é¼­ Áٱ⼼Æ÷¿¡ ¸Â´Â ¼¼Æ÷ºÐ¸® ±â¼úÀÇ ¹ßÀüÀÌ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.

°øµ¿¿¬±¸ ¹× ÆÄÆ®³Ê½Ê

Çаè, ¿¬±¸±â°ü, ¾÷°è °ü°èÀÚµé °£ÀÇ °øµ¿¿¬±¸°¡ Ȱ¼ºÈ­µÇ¸é¼­ ±â¼ú Çõ½ÅÀ» ÃËÁøÇÏ°í »õ·Î¿î ¼¼Æ÷ºÐ¸®¹ý °³¹ßÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼¼°èÀÇ ¼¼Æ÷ °Ý¸® ¹× ¼¼Æ÷ ºÐ¸® ½ÃÀå ¼Ò°³

  • ½ÃÀå °³¿ä
  • Á¶»ç ¹üÀ§
  • °¡Á¤

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå VERIFIED MARKET RESEARCH Á¶»ç ¹æ¹ý

  • µ¥ÀÌÅÍ ¸¶ÀÌ´×
  • ¹ë¸®µ¥À̼Ç
  • 1Â÷ ÀÚ·á
  • µ¥ÀÌÅÍ ¼Ò½º ¸®½ºÆ®

Á¦4Àå ¼¼°èÀÇ ¼¼Æ÷ °Ý¸® ¹× ¼¼Æ÷ ºÐ¸® ½ÃÀå Àü¸Á

  • °³¿ä
  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • Porter's Five Forces ¸ðµ¨
  • ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå ¼¼Æ÷ °Ý¸® ¹× ¼¼Æ÷ ºÐ¸® ¼¼°è ½ÃÀå : ¼¼Æ÷ À¯Çüº°

  • °³¿ä
  • Àΰ£ ¼¼Æ÷
  • µ¿¹° ¼¼Æ÷

Á¦6Àå ¼¼Æ÷ °Ý¸® ¹× ¼¼Æ÷ ºÐ¸® ¼¼°è ½ÃÀå : Á¦Ç°º°

  • °³¿ä
  • ¼Ò¸ðǰ
  • ±â±¸

Á¦7Àå ¼¼Æ÷ °Ý¸® ¹× ¼¼Æ÷ ºÐ¸® ¼¼°è ½ÃÀå : ±â¼úº°

  • °³¿ä
  • ¿ø½ÉºÐ¸® ±â¹Ý ¼¼Æ÷ ºÐ¸®
  • Ç¥¸é ¸¶Ä¿ ±â¹Ý ¼¼Æ÷ ºÐ¸®
  • ¿©°ú ±â¹Ý ¼¼Æ÷ ºÐ¸®

Á¦8Àå ¼¼Æ÷ °Ý¸® ¹× ¼¼Æ÷ ºÐ¸® ¼¼°è ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • °³¿ä
  • ¿¬±¸±â°ü¡¤¿¬±¸¼Ò
  • º´¿ø¡¤Áø´Ü ¿¬±¸¼Ò
  • ¼¼Æ÷ÀºÇà
  • ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö¡¤»ý¹° Á¦¾àȸ»ç

Á¦9Àå ¼¼Æ÷ °Ý¸® ¹× ¼¼Æ÷ ºÐ¸® ¼¼°è ½ÃÀå : ¿ëµµº°

  • °³¿ä
  • »ýü ºÐÀÚ ºÐ¸®
  • ¾Ï ¿¬±¸
  • Áٱ⼼Æ÷ Á¶»ç
  • Á¶Á÷ Àç»ý
  • ü¿ÜÁø´Ü
  • Ä¡·áÁ¦

Á¦10Àå ¼¼Æ÷ °Ý¸® ¹× ¼¼Æ÷ ºÐ¸® ¼¼°è ½ÃÀå : Áö¿ªº°

  • °³¿ä
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¼¼°è ±âŸ Áö¿ª
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå ¼¼°èÀÇ ¼¼Æ÷ °Ý¸® ¹× ¼¼Æ÷ ºÐ¸® ½ÃÀå °æÀï ±¸µµ

  • °³¿ä
  • °¢»çÀÇ ½ÃÀå ¼øÀ§
  • ÁÖ¿ä °³¹ß Àü·«

Á¦12Àå ±â¾÷ °³¿ä

  • Beckman Coulter(Subsidiary of Danaher Corporation)
  • Becton, Dickinson and Company
  • GE Healthcare(A Fully Owned Subsidiary of General Electric Company)
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Miltenyi Biotec

Á¦13Àå ÁÖ¿ä ¹ßÀü

  • Á¦Ç° Ãâ½Ã/°³¹ß
  • ÀμöÇÕº´
  • »ç¾÷ È®´ë
  • ÆÄÆ®³Ê½Ê°ú Á¦ÈÞ

Á¦14Àå ºÎ·Ï

  • °ü·Ã Á¶»ç
ksm 25.02.03

Global Cell Isolation Cell Separation Market Size and Forecast

Global Cell Isolation Cell Separation Market size was valued at USD 12.67 Billion in 2024 and is projected to reach USD 39.57 Billion by 2031 , growing at a CAGR of 16.87% from 2024 to 2031. Cell isolation and cell separation refer to techniques used to separate specific cell types from a heterogeneous mixture for research, diagnostics, or therapeutic purposes. These methods are crucial in fields like immunology, cancer research, and regenerative medicine, enabling scientists to study particular cell functions and behaviors in isolation. Applications include isolating immune cells for vaccine development, purifying stem cells for regenerative therapies, and separating tumor cells for cancer research.

The future of cell isolation and separation is promising, with advancements in technologies such as microfluidics and magnetic-activated cell sorting expected to enhance efficiency, accuracy, and scalability, thus broadening their applications in personalized medicine and cellular therapies.

Global Cell Isolation Cell Separation Market Dynamics

The key market dynamics that are shaping the global cell isolation cell separation market include:

Key Market Drivers:

Rising Prevalence of Chronic Diseases:

The increasing incidence of chronic diseases, including cancer and autoimmune disorders, drives the demand for cell isolation techniques. According to the World Health Organization (WHO), cancer cases are expected to rise to 29.5 million by 2040, necessitating advanced research methods for effective treatment.

Growth in Regenerative Medicine:

The expanding field of regenerative medicine is propelling the need for efficient cell separation methods. The global regenerative medicine market is projected to reach $90 billion by 2026, as reported by Fortune Business Insights, indicating a robust demand for isolating stem and progenitor cells for therapeutic applications.

Advancements in Technology:

Technological innovations in cell separation methods, such as microfluidics and automated cell sorting, are enhancing the efficiency and accuracy of cell isolation processes.

Increasing Investment in Research and Development:

Growing funding for biomedical research is fueling advancements in cell isolation and separation technologies. The National Institutes of Health (NIH) reported a budget of $47 billion for biomedical research in 2022, highlighting a significant investment that supports the development of novel cell isolation techniques for various applications.

Key Challenges:

High Costs of Technology:

The sophisticated equipment and reagents required for cell isolation and separation can be expensive, limiting access for smaller laboratories and institutions.

Technical Complexity:

Many cell separation techniques require specialized training and expertise, which can pose a barrier to widespread adoption in less equipped facilities.

Sample Contamination:

Ensuring the purity and integrity of isolated cells is challenging, as contamination can significantly affect research outcomes and therapeutic applications.

Regulatory Hurdles:

Navigating the regulatory landscape for cell-based products can be complex and time-consuming, potentially delaying market entry for new technologies.

Key Trends:

Integration of Automation

: Increasing automation in cell isolation and separation processes is enhancing efficiency and reproducibility, making these techniques more accessible to researchers.

Personalized Medicine Growth

: The trend towards personalized medicine is driving demand for precise cell isolation techniques, particularly for tailoring therapies based on individual patient profiles.

Focus on Stem Cell Research

: There is a growing emphasis on stem cell research and applications in regenerative medicine, prompting advancements in cell isolation technologies tailored for stem cells.

Collaboration and Partnerships

: Increased collaboration between academic institutions, research organizations, and industry players is fostering innovation and accelerating the development of novel cell separation methods.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Cell Isolation Cell Separation Market Regional Analysis

Here is a more detailed regional analysis of the global cell isolation cell separation market:

North America:

North America is the dominant region in the cell isolation and cell separation market, primarily due to its advanced healthcare infrastructure and substantial investment in biomedical research. The presence of leading pharmaceutical companies and research institutions drives demand for innovative cell isolation technologies. According to the National Institutes of Health (NIH), the U.S. alone allocated approximately $47 billion for biomedical research in 2022, significantly contributing to the development and application of cell separation techniques across various medical fields.

Moreover, the region's focus on personalized medicine and regenerative therapies has spurred the adoption of cell isolation methods. The increasing prevalence of chronic diseases, such as cancer and diabetes, necessitates precise cell-based treatments, further driving market growth. Reports indicate that the North American market for cell isolation technologies is expected to account for over 40% of the global market share by 2025, underscoring its leading position in this sector.

Asia Pacific:

The Asia Pacific region is emerging as the fastest growing market for cell isolation and cell separation technologies, driven by rapid advancements in healthcare and biotechnology. Countries like China and India are investing heavily in their biomedical research capabilities, aiming to enhance their global competitiveness. The Asian Development Bank reported that health expenditures in Asia are expected to reach $1 trillion by 2025, propelling demand for effective cell isolation methods in both research and clinical settings.

Additionally, the growing focus on stem cell research and regenerative medicine in Asia Pacific is a significant growth driver. The region's commitment to addressing chronic diseases and age-related health issues is fostering an environment conducive to innovation in cell separation technologies. As a result, the Asia Pacific market is projected to grow at a compound annual growth rate (CAGR) of over 10% from 2024 to 2030, highlighting its potential to surpass other regions in the coming years.

Global Cell Isolation Cell Separation Market: Segmentation Analysis

The Global Cell Isolation Cell Separation Market is segmented on the basis of By Cell Type, By Product, By Technique, By End User, By Application, and By Geography.

Global Cell Isolation Cell Separation Market, By Cell Type

  • Human Cells
  • Animal Cells

Based on Cell Type, the Global Cell Isolation Cell Separation Market is segmented into Human Cells, Animal Cells. The Animal Cells segment is dominant due to its extensive use in animal feed applications, where calcium formate enhances nutrition and health. However, the Human Cells segment is the fastest growing, driven by increasing research in regenerative medicine and cell therapies, which necessitate high-quality additives like calcium formate for cell culture and preservation.

Global Cell Isolation Cell Separation Market, By Product

  • Consumables
  • Instruments

Based on Product, the Global Cell Isolation Cell Separation Market is segmented into Consumables, Instruments. The Consumables segment is dominant, primarily due to the widespread use of calcium formate in various applications such as animal feed and concrete additives. Conversely, the Instruments segment is the fastest growing, driven by advancements in technology and increased demand for sophisticated equipment that improves the efficiency of calcium formate application processes.

Global Cell Isolation Cell Separation Market, By Technique

  • Centrifugation-Based Cell Isolation
  • Surface Marker-Based Cell Isolation
  • Filtration-Based Cell Isolation

Based on Technique, the Global Cell Isolation Cell Separation Market is segmented into Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation, Filtration-Based Cell Isolation. Surface Marker-Based Cell Isolation is the dominant segment, widely utilized for its specificity and efficiency in isolating particular cell types, particularly in research and clinical applications. Meanwhile, Centrifugation-Based Cell Isolation is the fastest growing segment, driven by advancements in centrifugation technologies that enhance separation processes and reduce processing time, making it increasingly popular in various biomedical fields.

Global Cell Isolation Cell Separation Market, By End User

  • Research Laboratories & Institutes
  • Hospitals & Diagnostic Laboratories
  • Cell Banks
  • Biotechnology & Biopharmaceutical Companies

Based on Product, the Global Cell Isolation Cell Separation Market is segmented into Research Laboratories & Institutes, Hospitals & Diagnostic Laboratories, Cell Banks, Biotechnology & Biopharmaceutical Companies. Research Laboratories & Institutes is the dominant segment, primarily due to the extensive use of calcium formate in various research applications, including cell culture and experimental procedures. However, the Biotechnology & Biopharmaceutical Companies segment is the fastest growing, driven by the increasing focus on developing innovative therapies and the rising demand for cell-based products, which necessitate advanced cell isolation techniques.

Global Cell Isolation Cell Separation Market, By Product

  • Biomolecule Isolation
  • Cancer Research
  • Stem Cell Research
  • Tissue Regeneration
  • In Vitro Diagnostics
  • Therapeutics

Based on Application, the Global Cell Isolation Cell Separation Market is segmented into Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration, In Vitro Diagnostics, Therapeutics. Cancer Research is the dominant segment due to the high demand for effective cell isolation techniques, which are critical for developing targeted cancer therapies. On the other hand, Stem Cell Research is the fastest growing segment, driven by the increasing focus on regenerative medicine and therapeutic advancements that require precise cell isolation and preservation methods.

Global Cell Isolation Cell Separation Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Based on the Geography, the Global Cell Isolation Cell Separation Market are classified into North America, Europe, Asia Pacific, and Rest of World. North America is the dominant region in the cell isolation and cell separation market, primarily due to its advanced healthcare infrastructure and substantial investment in biomedical research. The Asia Pacific region is emerging as the fastest growing market for cell isolation and cell separation technologies, driven by rapid advancements in healthcare and biotechnology.

Key Players

  • The "Global Cell Isolation Cell Separation Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market
  • Beckman Coulter (Subsidiary of Danaher Corporation), Becton, Dickinson and Company, GE Healthcare (A Fully Owned Subsidiary of General Electric Company), Merck KGaA, Thermo Fisher Scientific Inc., Miltenyi Biotec.
  • Our
  • market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
  • Global Cell Isolation Cell Separation Market: Recent Developments
  • In August 2024 Becton, Dickinson and Company announced the launch of a new line of advanced cell separation kits that utilize innovative microfluidics technology. These kits are designed to enhance the efficiency and accuracy of isolating specific cell types for research and clinical applications, significantly improving throughput and reducing processing times for laboratories.
  • In July 2024 Miltenyi Biotec unveiled a state-of-the-art cell sorting system that integrates artificial intelligence for optimized sorting protocols. This system allows researchers to achieve higher purity levels in isolated cell populations while reducing user intervention, making it easier for laboratories to handle complex cell separation tasks.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CELL ISOLATION/CELL SEPARATION MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL CELL ISOLATION/CELL SEPARATION MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, BY CELL TYPE

  • 5.1 Overview
  • 5.2 Human Cells
  • 5.3 Animal Cells

6 GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, BY PRODUCT

  • 6.1 Overview
  • 6.2 Consumables
  • 6.3 Instruments

7 GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, BY TECHNIQUE

  • 7.1 Overview
  • 7.2 Centrifugation-Based Cell Isolation
  • 7.3 Surface Marker-Based Cell Isolation
  • 7.4 Filtration-Based Cell Isolation

8 GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, BY END USER

  • 8.1 Overview
  • 8.2 Research Laboratories & Institutes
  • 8.3 Hospitals & Diagnostic Laboratories
  • 8.4 Cell Banks
  • 8.5 Biotechnology & Biopharmaceutical Companies

9 GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, BY APPLICATION

  • 9.1 Overview
  • 9.2 Biomolecule Isolation
  • 9.3 Cancer Research
  • 9.4 Stem Cell Research
  • 9.5 Tissue Regeneration
  • 9.6 In Vitro Diagnostics
  • 9.7 Therapeutics

10 GLOBAL CELL ISOLATION/CELL SEPARATION MARKET, BY GEOGRAPHY

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 U.K.
    • 10.3.3 France
    • 10.3.4 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Rest of Asia Pacific
  • 10.5 Rest of the World
    • 10.5.1 Latin America
    • 10.5.2 Middle East and Africa

11 GLOBAL CELL ISOLATION/CELL SEPARATION MARKET COMPETITIVE LANDSCAPE

  • 11.1 Overview
  • 11.2 Company Market Ranking
  • 11.3 Key Development Strategies

12 COMPANY PROFILES

  • 12.1 Beckman Coulter (Subsidiary of Danaher Corporation)
    • 12.1.1 Overview
    • 12.1.2 Financial Performance
    • 12.1.3 Product Outlook
    • 12.1.4 Key Developments
  • 12.2 Becton, Dickinson and Company
    • 12.2.1 Overview
    • 12.2.2 Financial Performance
    • 12.2.3 Product Outlook
    • 12.2.4 Key Developments
  • 12.3 GE Healthcare (A Fully Owned Subsidiary of General Electric Company)
    • 12.3.1 Overview
    • 12.3.2 Financial Performance
    • 12.3.3 Product Outlook
    • 12.3.4 Key Developments
  • 12.4 Merck KGaA
    • 12.4.1 Overview
    • 12.4.2 Financial Performance
    • 12.4.3 Product Outlook
    • 12.4.4 Key Developments
  • 12.5 Thermo Fisher Scientific Inc.
    • 12.5.1 Overview
    • 12.5.2 Financial Performance
    • 12.5.3 Product Outlook
    • 12.5.4 Key Developments
  • 12.6 Miltenyi Biotec
    • 12.6.1 Overview
    • 12.6.2 Financial Performance
    • 12.6.3 Product Outlook
    • 12.6.4 Key Developments

13 KEY DEVELOPMENTS

  • 13.1 Product Launches/Developments
  • 13.2 Mergers and Acquisitions
  • 13.3 Business Expansions
  • 13.4 Partnerships and Collaborations

14 Appendix

  • 14.1 Related Research
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦